Bayesian meta-analysis and meta-regression for gene-disease associations and deviations from Hardy-Weinberg equilibrium

Statistics in Medicine

Volumn 26, Issue 3, 2007, Pages 553-567

  Salanti, Georgia ^a   Higgins, Julian P T ^a   Trikalinos, Thomas A ^b,c   Ioannidis, John P A ^b,c  

^a MRC BIOSTATISTICS UNIT   (United Kingdom)

^b UNIVERSITY OF IOANNINA   (Greece)

^c TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Fixation coefficient; Heterogeneity; Hierarchical model; Polymorphism

Indexed keywords

ANGIOTENSIN; ARYLDIALKYLPHOSPHATASE 1; DIPEPTIDYL CARBOXYPEPTIDASE; DOPAMINE 3 RECEPTOR; FC RECEPTOR; FIBRINOGEN RECEPTOR; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2);

ALZHEIMER DISEASE; ARTICLE; BAYES THEOREM; BIOMETRY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; DISEASE ASSOCIATION; GENE DELETION; GENE FREQUENCY; GENE INSERTION; GENE LOCUS; GENE MUTATION; GENE POOL; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; ISCHEMIC HEART DISEASE; MONTE CARLO METHOD; POPULATION GENETICS; REGRESSION ANALYSIS; SCHIZOPHRENIA; SYSTEMATIC REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS; VENOUS THROMBOEMBOLISM;

ALLELES; BAYES THEOREM; CASE-CONTROL STUDIES; GENETIC MARKERS; HUMANS; META-ANALYSIS; MODELS, GENETIC; REGRESSION ANALYSIS;

EID: 33846425396     PISSN: 02776715     EISSN: 10970258     Source Type: Journal    
DOI: 10.1002/sim.2575     Document Type: Article

References (46)

1. Emigh T. A comparison of tests for Hardy-Weinberg equilibrium. Biometrics 1980; 36:627-642.
2. Ginsburg EK, Axenovich TI, Babenko VN. Comparison of asymptotic tests of the Hardy-Weinberg distribution. Annals of Human Genetics 1991; 55(Part 4):329-338.
3. Salanti G, Amountza G, Ntzani EE, Ioannidis JP. Hardy-Weinberg equilibrium in genetic association studies: an empirical evaluation of reporting, deviations, and power. European Journal of Human Genetics 2005; 13: 840-848.
4. Wittke-Thompson JK, Pluzhnikov A, Cox NJ. Rational inferences about departures from Hardy-Weinberg equilibrium. American Journal of Human Genetics 2005; 76:967-986.
5. Weinberg CR, Morris RW. Invited commentary. Testing for Hardy-Weinberg disequilibrium using a genome single-nucleotide polymorphism scan based on cases only. American Journal of Epidemiology 2003; 158: 401-403.
6. Lee WC. Searching for disease-susceptibility loci by testing for Hardy-Weinberg disequilibrium in a gene bank of affected individuals. American Journal of Epidemiology 2003; 158:397-400.
7. Khoury MJ, Beaty TH, Cohen BH. Fundamentals of genetic epidemiology. In Monographs in Epidemiology and Biostatistics, Kelsey J, Vessey M, Stolley P (eds). New York, 1993.
8. Ioannidis JP, Ntzani EE, Trikalinos TA. 'Racial' differences in genetic effects for complex diseases. Nature Genetics 2004; 36:1312-1318.
9. Thomas DC, Witte JS. Point: population stratification: a problem for case-control studies of candidate-gene associations? Cancer Epidemiology Biomarkers and Prevention 2002; 11:505-512.
10. Wacholder S, Rothman N, Caporaso N. Counterpoint: bias from population stratification is not a major threat to the validity of conclusions from epidemiological studies of common polymorphisms and cancer. Cancer Epidemiology Biomarkers and Prevention 2002; 11:513-520.
11. Ioannidis JP. Genetic associations: false or true? Trends in Molecular Medicine 2003; 9:135-138.
12. Schaid DJ, Jacobsen SJ. Biased tests of association: comparisons of allele frequencies when departing from Hardy-Weinberg proportions. American Journal of Epidemiology 1999; 149:706-711.
13. Sasieni PD. From genotypes to genes: doubling the sample size. Biometrics 1997; 53:1253-1261.
14. Xu J, Turner A, Little J, Bleecker ER, Meyers DA. Positive results in association studies are associated with departure from Hardy-Weinberg equilibrium: hint for genotyping error? Human Genetics 2002; 111:573-574.
15. Khoury MJ, Little J. Human genome epidemiologic reviews: the beginning of something HuGE. American Journal of Epidemiology 2000; 151:2-3.
16. Lathrop GM. Estimating genotype relative risks. Tissue Antigens 1983; 22:160-166.
17. Attia J, Thakkinstian A, D'Este C. Meta-analyses of molecular association studies: methodologic lessons for genetic epidemiology. Journal of Clinical Epidemiology 2003; 56:297-303.
18. Salanti G, Sanderson S, Higgins JP. Obstacles and opportunities in meta-analysis of genetic association studies. Genetics in Medicine 2005; 7:13-20.
19. Thakkinstian A, McElduff P, D'Este C, Duffy D, Atria J. A method for meta-analysis of molecular association studies. Statistics in Medicine 2004.
20. Trikalinos TA, Salanti G, Khoury MJ, Ioannidis JP. Impact of violations and deviations in Hardy-Weinberg equilibrium on postulated gene-disease associations. American Journal of Epidemiology 2006; 163:300-309.
21. Nam JM. Testing a genetic equilibrium across strata. Annals of Human Genetics 1997; 61 (Part 2):163-170.
22. Seaman SR, Richardson S. Bayesian analysis of case-control studies with categorical covariates. Biometrika 2001; 88:1073-1088.
23. Satten GA, Epstein MP. Comparison of prospective and retrospective methods for haplotype inference in case-control studies. Genetic Epidemiology 2005; 27:192-201.
24. Shoemaker J, Painter I, Weir BS. A Bayesian characterization of Hardy-Weinberg disequilibrium. Genetics 1998; 149:2079-2088.
25. Seaman SR, Richardson S. Equivalence of prospective and retrospective models in the Bayesian analysis of case-control studies. Biometrika 2004; 91:15-25.
26. Minelli C, Thompson JR, Abrams KR, Lambert PC. Bayesian implementation of a genetic model-free approach to the meta-analysis of genetic association studies. Statistics in Medicine 2005; 24:3845-3861.
27. Cheng KF, Chen JH. Bayesian models for population-based case-control studies when the population is in Hardy-Weinberg equilibrium. Genetic Epidemiology 2005; 28:183-192.
28. Miettinen O. Estimability and estimation in case-referent studies. American Journal of Epidemiology 1976; 103:226-235.
29. Thompson SG, Smith TC, Sharp SJ. Investigating underlying risk as a source of heterogeneity in meta-analysis. Statistics in Medicine 1997; 16:2741-2758.
30. Malec D, Sedransk J. Bayesian methodology for combining the results from different experiments when the specifications for pooling are uncertain. Biometrika 1992; 79:593-502.
31. Aitkin M. Meta-analysis by random effect modelling in generalized linear models. Statistics in Medicine 1999; 18:2343-2351.
32. Lambert PC, Sutton AJ, Burton PR, Abrams KR, Jones DR. How vague is vague? A simulation study of the impact of the use of vague prior distributions in MCMC using WinBUGS. Statistics in Medicine 2005; 24:2401-2428.
33. Ioannidis JP, Trikalinos TA, Ntzani EE, Contopoulos-Ioannidis DG. Genetic associations in large versus small studies: an empirical assessment. Lancet 2003; 361:567-571.
34. Ioannidis JP, Ntzani EE, Trikalinos TA, Contopoulos-Ioannidis DG. Replication validity of genetic association studies. Nature Genetics 2001; 29:306-309.
35. Di Castelnuovo A, de Gaetano G, Donati MB, Iacoviello L. Platelet glycoprotein receptor IIIa polymorphism PLA1/PLA2 and coronary risk: a meta-analysis. Thrombosis and Haemostasis 2001; 85:626-633.
36. Jonsson EG, Flyckt L, Burgert E, Crocq MA, Forslund K, Mattila-Evenden M et al. Dopamine D3 receptor gene Ser9Gly variant and schizophrenia: association study and meta-analysis. Psychiatry Genetics 2003; 13:1-12.
37. Karassa FB, Trikalinos TA, Ioannidis JP. The Fc gamma RIIIA-F158 allele is a risk factor for the development of lupus nephritis: a meta-analysis. Kidney International 2003; 63:1475-1482.
38. Kehoe PG, Katzov H, Feuk L, Bennet AM, Johansson B, Wiman B et al. Haplotypes extending across ACE are associated with Alzheimer's disease. Human Molecular Genetics 2003; 12:859-867.
39. Ray JG, Shmorgun D, Chan WS. Common C677T polymorphism of the methylenetetrahydrofolate reductase gene and the risk of venous thromboembolism: meta-analysis of 31 studies. Pathophysiol Haemostasis and Thrombosis 2002; 32:51-58.
40. Sethi AA, Nordestgaard BG, Tybjaerg-Hansen A. Angiotensinogen gene polymorphism, plasma angiotensinogen, and risk of hypertension and ischemic heart disease: a meta-analysis. Arterioscler Thrombosis Vascular Biologie 2003; 23:1269-1275.
41. Wheeler JG, Keavney BD, Watkins H, Collins R, Danesh J. Four paraoxonase gene polymorphisms in 11212 cases of coronary heart disease and 12786 controls: meta-analysis of 43 studies. Lancet 2004; 363:689-695.
42. Spiegelhalter DJ, Thomas A, Best NG, Lunn D. WinBUGS Version 1.4 Users Manual. MRC Biostatistics Unit, Cambridge, 2003.
43. Pati N, Pati U. Paraoxonase gene polymorphism and coronary artery disease in Indian subjects. International Journal of Cardiology 1998; 66:165-168.
44. Ioannidis JPA. Why most published research findings are false. PLoS Medicine 2005; 2:e124.
45. Hirschhorn JN, Lohmueller K, Byrne E, Hirschhorn K. A comprehensive review of genetic association studies. Genetics in Medicine 2002; 4:45-61.
46. Colhoun HM, McKeigue PM, Davey Smith G. Problems of reporting genetic associations with complex outcomes. Lancet 2003; 361:865-872.